You are here:

Archived: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg and 300mg capsules (Lyrica®)

Advice

Following a full submission

Pregabalin (Lyrica) is not recommended for use within NHS Scotland for the treatment of peripheral neuropathic pain in adults. The comparative clinical and cost effectiveness have not been demonstrated.

The licence holder has indicated their decision to resubmit

Drug Details

Drug Name: Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg and 300mg capsules (Lyrica®)
SMC Drug ID: 157/05
Manufacturer: Pfizer Ltd
Indication: Peripheral neuropathic pain
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 7 March 2005

Current Advice

Resubmission 11 May 2009

Archived Advice

IRP 7 August 2006
Resubmission 15 August 2005

Back